Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells
Open Access
- 15 March 2004
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 117 (8), 1365-1379
- https://doi.org/10.1242/jcs.01037
Abstract
In MDCK cells, hepatocyte growth factor/scatter factor (HGF/SF) induces epithelial cell dissociation, scattering, migration, growth and formation of branched tubular structures. By contrast, these cells neither scatter nor form tubular structures in response to the epidermal growth factor (EGF) family of growth factors. Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of growth factors and is synthesized as a membrane-associated precursor molecule (proHB-EGF). ProHB-EGF is proteolytically cleaved to release a soluble ligand (sHB-EGF) that activates the EGF receptor. Although recent studies suggest possible physiological functions, the role of proHB-EGF remains largely undefined. Using MDCK cells stably expressing proHB-EGF, a noncleavable deletion mutant of proHB-EGF or soluble HB-EGF, we show that epithelial cell functions differ depending on the form of HB-EGF being expressed. Expression of noncleavable membrane-anchored HB-EGF promoted cell-matrix and cell-cell interactions and decreased cell migration, HGF/SF-induced cell scattering and formation of tubular structures. By contrast, expression of soluble HB-EGF induced increased cell migration, decreased cell-matrix and cell-cell interactions and promoted the development of long unbranched tubular structures in response to HGF/SF. These findings suggest that HB-EGF can not only modulate HGF/SF-induced cellular responses in MDCK cells but also that membrane-bound HB-EGF and soluble HB-EGF give rise to distinctly different effects on cell-cell and cell-extracellular matrix interactions.Keywords
This publication has 67 references indexed in Scilit:
- Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma linesInternational Journal of Cancer, 2002
- Integral Role of the EGF Receptor in HGF-Mediated Hepatocyte ProliferationBiochemical and Biophysical Research Communications, 2002
- Sustained Activation of Extracellular Signal-regulated Kinase Stimulated by Hepatocyte Growth Factor Leads to Integrin α2 Expression That Is Involved in Cell ScatteringJournal of Biological Chemistry, 2001
- Identification of Serum Factor Inducing Ectodomain Shedding of proHB-EGF and Studies of Noncleavable Mutants of proHB-EGFBiochemical and Biophysical Research Communications, 2001
- HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migrationKidney International, 2001
- Localization of CD9, an Enhancer Protein for Proheparin-Binding Epidermal Growth Factor–Like Growth Factor, in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Contact-dependent Growth Inhibition and Apoptosis of Epidermal Growth Factor (EGF) Receptor-expressing Cells by the Membrane-anchored Form of Heparin-binding EGF-like Growth FactorJournal of Biological Chemistry, 1999
- Hepatocyte growth factor and Madin-Darby canine kidney cells: In vitro models of epithelial cell movement and morphogenesisMicroscopy Research and Technique, 1998
- Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel PathwayJournal of Biological Chemistry, 1998
- Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.The Journal of cell biology, 1995